(Q36659424)

English

Homodimerization of tumor-reactive monoclonal antibodies markedly increases their ability to induce growth arrest or apoptosis of tumor cells

scientific article published on July 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 August 2017

Homodimerization of tumor-reactive monoclonal antibodies markedly increases their ability to induce growth arrest or apoptosis of tumor cells (English)

1 reference

Europe PubMed Central

15 August 2017

1 reference

based on heuristic

inferred from title

monoclonal antibody

1 reference

based on heuristic

inferred from title

apoptotic process

1 reference

based on heuristic

inferred from title

6

object named as

E S Vitetta

1 reference

Europe PubMed Central

15 August 2017

5

object named as

J W Uhr

1 reference

Europe PubMed Central

15 August 2017

Maria-Ana Ghetie

1

object named as

M A Ghetie

1 reference

Europe PubMed Central

15 August 2017

author name string

E M Podar

2

1 reference

Europe PubMed Central

15 August 2017

A Ilgen

3

1 reference

Europe PubMed Central

15 August 2017

B E Gordon

4

1 reference

Europe PubMed Central

15 August 2017

language of work or name

0 references

publication date

1 July 1997

1 reference

Europe PubMed Central

15 August 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

Proceedings of the National Academy of Sciences of the United States of America

1 reference

Europe PubMed Central

15 August 2017

94

1 reference

Europe PubMed Central

15 August 2017

7509-7514

1 reference

Europe PubMed Central

15 August 2017

14

1 reference

Europe PubMed Central

15 August 2017

Antibodies as cytotoxic therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23852

30 September 2017

Monoclonal antibodies as agonists: an expanded role for their use in cancer therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23852

30 September 2017

Integrins and other adhesion molecules involved in melanocytic tumor progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23852

30 September 2017

A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23852

30 September 2017

Immunoconjugates and immunotoxins for therapy of carcinomas.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23852

30 September 2017

IgG2a monoclonal antibodies inhibit human tumor growth through interaction with effector cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23852

30 September 2017

PKCALC: a BASIC interactive computer program for statistical and pharmacokinetic analysis of data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23852

30 September 2017

Genetically engineered antibody molecules

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23852

30 September 2017

Therapy of lymphoma directed at idiotypes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23852

30 September 2017

Engineered humanized dimeric forms of IgG are more effective antibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23852

30 September 2017

Features of apoptotic cells measured by flow cytometry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23852

30 September 2017

Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23852

30 September 2017

Recombinant polymeric IgG: an approach to engineering more potent antibodies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23852

28 June 2018

Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23852

28 June 2018

Fc gamma receptor II (CD32) on malignant B cells influences modulation induced by anti-CD19 monoclonal antibody

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23852

28 June 2018

Anti-CD19 inhibits the growth of human B-cell tumor lines in vitro and of Daudi cells in SCID mice by inducing cell cycle arrest

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23852

28 June 2018

Preliminary experience in treating lymphocytic leukaemia with antibody to immunoglobulin idiotypes on the cell surfaces

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23852

28 June 2018

Therapeutic potential of rat monoclonal antibodies: isotype specificity of antibody-dependent cell-mediated cytotoxicity with human lymphocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23852

28 June 2018

Lymphoma models for B-cell activation and tolerance. II. Growth inhibition by anti-mu of WEHI-231 and the selection and properties of resistant mutants.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23852

28 June 2018

Role of phosphoinositide-derived second messengers in mediating anti-IgM-induced growth arrest of WEHI-231 B lymphoma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23852

28 June 2018

Monoclonal antibody-mediated tumor regression by induction of apoptosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23852

28 June 2018

Disseminated or localized growth of a human B-cell tumor (Daudi) in SCID mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23852

28 June 2018

Anti-IgM-mediated growth inhibition of a human B lymphoma cell line is independent of phosphatidylinositol turnover and protein kinase C activation and involves tyrosine phosphorylation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23852

28 June 2018

Effect of light chain V region duplication on IgG oligomerization and in vivo efficacy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23852

28 June 2018

The GLP large scale preparation of immunotoxins containing deglycosylated ricin A chain and a hindered disulfide bond.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23852

28 June 2018

p185HER2 signal transduction in breast cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23852

28 June 2018

An unmodified anticarcinoma antibody, BR96, localizes to and inhibits the outgrowth of human tumors in nude mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23852

28 June 2018

The antitumor activity of an anti-CD22 immunotoxin in SCID mice with disseminated Daudi lymphoma is enhanced by either an anti-CD19 antibody or an anti-CD19 immunotoxin.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23852

28 June 2018

Identifying amino acid residues that influence plasma clearance of murine IgG1 fragments by site-directed mutagenesis.

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.94.14.7509

21 January 2018

Noncompartmental determination of the steady-state volume of distribution for any mode of administration.

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.94.14.7509

21 January 2018

Tumour pharmacokinetics?--we do need to know

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.94.14.7509

21 January 2018

REMISSION INDUCTION IN NON-HODGKIN LYMPHOMA WITH RESHAPED HUMAN MONOCLONAL ANTIBODY CAMPATH-1H

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.94.14.7509

21 January 2018

Engineering Antibodies for Therapy

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.94.14.7509

21 January 2018

Antibody-targeted lymphokine-activated killer cells inhibit liver micrometastases in severe combined immunodeficient mice

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.94.14.7509

21 January 2018

Efficient induction of apoptosis in cultured rat glomerular mesangial cells by dimeric monoclonal IgA anti-Thy-1 antibodies

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.94.14.7509

21 January 2018

Selective in vivo antitumor effects of monoclonal anti-I-A antibody on B cell lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9207122

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of ricin A chain-containing immunotoxins directed against CD19 and CD22 antigens on normal and malignant human B-cells as potential reagents for in vivo therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/9207122

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of CAMPATH-1 antibodies in vivo in patients with lymphoid malignancies: influence of antibody isotype

1 reference

https://pubmed.ncbi.nlm.nih.gov/9207122

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of human B-cell lymphoma growth by CD40 stimulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/9207122

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhanced antitumor effects of CD20 over CD19 monoclonal antibodies in a nude mouse xenograft model

1 reference

https://pubmed.ncbi.nlm.nih.gov/9207122

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Eradication of large human B cell tumors in nude mice with unconjugated CD20 monoclonal antibodies and interleukin 2

1 reference

https://pubmed.ncbi.nlm.nih.gov/9207122

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Engineering multiple-domain forms of the therapeutic antibody CAMPATH-1H: effects on complement lysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9207122

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumour dormancy and cell signalling--III: Role of hypercrosslinking of IgM and CD40 on the induction of cell cycle arrest and apoptosis in B lymphoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/9207122

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endocytosis and degradation of monoclonal antibodies targeting human B-cell malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/9207122

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A genetically engineered human IgG mutant with enhanced cytolytic activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/9207122

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-B4-blocked ricin immunotoxin shows therapeutic efficacy in four different SCID mouse tumor models

1 reference

https://pubmed.ncbi.nlm.nih.gov/9207122

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monoclonal antibody homodimers: enhanced antitumor activity in nude mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/9207122

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of antibody isotype on passive serotherapy of lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9207122

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Importance of antibody isotype in monoclonal anti-idiotype therapy of a murine B cell lymphoma. A study of hybridoma class switch variants

1 reference

https://pubmed.ncbi.nlm.nih.gov/9207122

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1073/PNAS.94.14.7509

1 reference

Europe PubMed Central

15 August 2017

1997PNAS...94.7509G

0 references

1 reference

Europe PubMed Central

15 August 2017

1 reference

Europe PubMed Central

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36659424&oldid=2107974009"